Details of the Drug Reposition

General Information of This Drug (ID: DM45BHM)

Drug Name
CEA CAR-T   DM45BHM
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Peritoneal metastasis DISSVVJ5 2D91 Phase 1 [1]
Ascites DISYTEHD ME04 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Sorrento Therapeutics.